Event Details:
Veravas is excited to host an upcoming webinar on techniques and methodologies for ultra sensitive saliva biomarker detection.
January 31, 2023
12pm EST / 11am CST / 9am PST
The Discussion:
Hosted by Josh Soldo [Veravas CSO and Co-Founder), this webinar will feature a panel of experts who will discuss the latest advances in this field and how they enable the use of saliva samples for biomarker detection.
The panelists will discuss a variety of topics, including the different methods used for ultra sensitive biomarker detection, the benefits of using saliva samples, and the potential applications of this technology. They will also address common challenges and limitations in this field, and provide insights on how to overcome them.
Attendees of this webinar will have the opportunity to learn from leading experts and ask questions in real time. Whether you are a researcher, healthcare provider, or simply interested in learning more about this exciting topic, we encourage you to join us for this informative and engaging discussion.
Speakers:
Ronald C. McGlennen, MD, President and Medical Director, OralDNA LabsAvi M. Robbins,
President of Porex Life Sciences Institute
Avi has nearly 20 years’ experience in medical device, diagnostics, and healthcare related industries with roles spanning product development, sales, operations, and general management. He most recently lead the formation of the Porex Life Sciences Institute which is currently focused on democratizing access to saliva based diagnostics by improving the saliva collection and processing workflows.
Dr. McGlennen is an Associate Professor of Pathology at the University of Minnesota Medical School. He has published more than 70 scientific articles and book chapters and is the editor of five journals. He holds 9 issued and pending patents. He is board certified in Anatomic and Clinical Pathology and also by the American Board of Medical Genetics, with a Specialty in Clinical Molecular Genetics.
Josh Soldo,
Co-Founder and Chief Scientific Officer, VeravasModerator:
Josh is a global scientific affairs executive and innovation leader in Diagnostics and is considered a subject matter expert in assay development and solid phase chemistry. He is the inventor of VeraPrep™ which uses proprietary nanoparticles to reduce the effects of assay interferences and for the enrichment and multiplex detection of low abundance biomarkers. Over the past 20 years he has held a variety of research, medical & scientific affairs and leadership roles for Roche, Anteo Technologies, DiaSorin, and Beckman Coulter.
Register: